tesamorelin/ ipamorelin Tesamorelin + (10mg/3mg) TESAMORELIN/IPAMORELIN (8/2MG)
Description
Sermorelin was originally approved by the FDA in 1997 for treating growth hormone deficiency in children, but was discontinued in 2008 due to manufacturing issues, not safety concerns
Ethical Approval This study was approved by the Institutional Animal Care and Use Committee of Washington State University and conducted in accordance with National Institutes of Healths Guidelines for the Care and Use of Laboratory Animals
Are GHRPs on the WADA list
10.1016/s0304-3940(01)01855-9 282 ZhuG.WangX.ChenY.YangS.ChengH.WangN.et al (2010)
